Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2865174 | The American Journal of the Medical Sciences | 2010 | 5 Pages |
Abstract
Chemotherapy and radiation therapy administered for breast cancer predispose patients to the development of MDS or AML. We hypothesize that the breast cancer (BRCA) gene mutations might add to the risk and that primary care physicians must be aware of the long-term risks of cytotoxic therapy, including the development of MDS or AML.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marion MD, Roger MD, PhD,